| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |